Bortezomib structure
Bortezomib
Yellow SolidChEBI: L-Phenylalaninamide substituted at the amide nitrogen by a 1-(dihydroxyboranyl)-3-methylbutyl group and at Nalpha by a pyrazin-2-ylcarbonyl group. It is a dipeptidyl boronic acid tha reversibly inhibits the 26S proteasome.Bortezomib, a modified dipeptidyl boronic acid, is a therapeutic proteasome inhibitors used for the treatment of cancers. It is indicated for the treatment of relapsed multiple myeloma and mantle cell lymphoma. It is capable of inhibiting the mammalian 26S
Find 52 Related Holders
ZHEJIANG HISUN PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Inactive
ASH STEVENS INC
United States
United States
API Registration Country
API Inactive
Recommended Suppliers of Bortezomib
-
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier -
Shanghai Lonwin Chemical Co.,Ltd
CN1 YR
Contact Supplier -
Echemi Pharmaceutical
CN1 YR
Contact Supplier -
Nanjing Paron Technology Co., Ltd
CN1 YR
Contact Supplier -
Hong Kong Lemite Group Limited
HK1 YR
Contact Supplier